Bloomberg BNA Pharma Pay-For-Delay Deals Called ‘Cost of Doing Business’ Pay-for-delay now manifests in creative and “insidious” ways, said Sinha, who is also a visiting scholar at Northeastern University School of Law’s Center for Health Policy.